Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases

The Lancet Oncology
Ingrid Herr, Jesco Pfitzenmaier

Abstract

Glucocorticoids have been used widely in conjunction with other treatment for patients with cancer because they have potent proapoptotic properties in lymphoid cells, can reduce nausea, and alleviate acute toxic effects in healthy tissue. However, glucocorticoids are used in a supportive-care role, even though to our knowledge no prospective clinical studies have assessed the effect of these steroids on the growth of solid tumours. Data from preclinical and, to some extent, clinical studies, suggest that glucocorticoids induce treatment resistance in solid tumours, including prostate cancer. Research has focussed on disseminated cells that have been shed by the tumour: the potential of glucocorticoids to render these cells resistant to apoptosis--and to downregulate the immune response--might contribute to tumour metastasis. Here, we review the benefits of glucocorticoids and their negative effects, such as induction of resistance in tumour cells and concomitant induction of apoptosis in immune cells, with particular emphasis on prostate cancer.

References

May 14, 1981·The New England Journal of Medicine·M Haid
Mar 6, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·H P RutzR O Mirimanoff
Feb 23, 2000·Neuroscience·A M GormanS Ceccatelli
Dec 19, 2000·Biochemical and Biophysical Research Communications·S L Planey, G Litwack
Jul 28, 1962·JAMA : the Journal of the American Medical Association·P SHERLOCK, W H HARTMANN
May 1, 1952·Proceedings of the Society for Experimental Biology and Medicine·M AGOSINA JARPA
Jul 10, 2004·Acta Anaesthesiologica Scandinavica·M P YeagerA U Munck
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Jan 1, 2005·Current Opinion in Oncology·Olga Frankfurt, Steven T Rosen
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Kenneth J Pienta, David C Smith

❮ Previous
Next ❯

Citations

Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ingrid HerrMarkus W Büchler
Jan 26, 2007·Clinical and Experimental Pharmacology & Physiology·Andrew J Brown
Mar 23, 2013·Journal of Translational Medicine·Soraya L VallesJosé M Estrela
Sep 8, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Evelina CittadinoEnzo Terreno
Apr 22, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Luciana Rocha ViegasAdali Pecci
Jul 14, 2011·Journal of Cellular Biochemistry·Veronika TothovaAdriana Gibadulinova
Apr 12, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Stella LogothetiVassilis Zoumpourlis
Aug 28, 2009·International Journal of Cancer. Journal International Du Cancer·Halis SuleymanAhmet Hacimuftuoglu
Aug 8, 2015·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·David B CochranThomas D Dziubla
Aug 2, 2011·Journal of Chemotherapy·Jian HuangChengwen Zhang
Aug 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chun YangKristi S Anseth
Nov 21, 2012·Brain, Behavior, and Immunity·Paul A Volden, Suzanne D Conzen
Feb 1, 2014·Toxicology and Applied Pharmacology·David AguilarQin M Chen
Apr 27, 2016·Journal of Cellular Physiology·Simra AzherNicola Cirillo
Jul 16, 2016·Stress : the International Journal on the Biology of Stress·Lubica HorvathovaBoris Mravec
Mar 13, 2008·Forschende Komplementärmedizin = Research in Complementary Medicine·Annette Loewe-MeschCornelia v Hagens
Jan 31, 2017·International Journal of Molecular Sciences·Keisuke OtaniKazuhiko Ogawa
Jan 10, 2018·Hormones & Cancer·Vladimir DjedovicTheodore J Brown
Sep 22, 2018·Journal of Cellular Physiology·Antonio CelentanoNicola Cirillo
Mar 10, 2020·Expert Opinion on Therapeutic Patents·Marianna LucafòGabriele Stocco
Sep 15, 2020·Journal of Biomolecular Structure & Dynamics·Adewale Oluwaseun FadakaMervin Meyer
Sep 2, 2020·Cellular & Molecular Immunology·Linda Quatrini, Sophie Ugolini
Jan 11, 2019·Pharmaceutics·Catarina Oliveira SilvaCatarina Reis
Oct 22, 2015·Journal of Thoracic Imaging·Yoshinao SatoKei Takase

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Apoptosis : an International Journal on Programmed Cell Death
Ingrid HerrMarkus Büchler
The New England Journal of Medicine
Ching-Hon Pui, William E Evans
Journal of Controlled Release : Official Journal of the Controlled Release Society
Manuela BanciuRaymond M Schiffelers
© 2022 Meta ULC. All rights reserved